SILK — Silk Road Medical Cashflow Statement
0.000.00%
Last trade - 00:00
- $1.12bn
- $1.02bn
- $177.13m
- 57
- 17
- 93
- 56
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -52.4 | -47.4 | -49.8 | -55 | -55.7 |
Depreciation | |||||
Non-Cash Items | 25.1 | 9.7 | 16.3 | 26.3 | 34.9 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -3.05 | -5.19 | -6.48 | -6.03 | -13.9 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -29.6 | -42.1 | -38.9 | -32.6 | -32 |
Capital Expenditures | -0.535 | -0.842 | -4.76 | -5 | -1.51 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -69.4 | -8.55 | 77.4 | -157 | -5.67 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -70 | -9.39 | 72.6 | -162 | -7.18 |
Financing Cash Flow Items | 0 | — | 0.032 | — | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 114 | 81.7 | 6.98 | 140 | 3.89 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 14.2 | 30.3 | 40.7 | -55 | -35.3 |